当前位置: 首页 > 期刊 > 《糖尿病新世界》 > 2017年第15期
编号:13223028
蒙药降糖1号治疗糖尿病的临床疗效观察(1)
http://www.100md.com 2017年8月1日 糖尿病新世界 2017年第15期
     [摘要] 目的 探讨对糖尿病患者给予蒙药希合日希精阿日乐嘎其(降糖1号)治疗的临床疗效。方法 选用2016年4月—2017年4月该院收治的160例糖尿病患者作为观察对象,采用随机分组法分成参照组和研究组,每组80例。参照组采用格列本脲治疗,研究组采用蒙药希合日希精阿日乐嘎其(降糖1号)治疗,连续治疗4周,观察两组治疗效果。 结果 研究组总有效率明显优于参照组(P<0.05);研究组不良反应明显低于对参照组(P<0.05),研究组治疗后血液流变学各指标较治疗前均有所改善(P<0.05)。结论 蒙药希合日希精阿日乐嘎其能够有效缓解患者临床症状,降低患者血糖,改善血液流变学指标,减少患者痛苦,提高患者生活质量,优化治疗效果,减少不良反应,疗效安全可靠,值得选用。

    [关键词] 糖尿病;蒙药降糖1号;临床效果

    [中图分类号] R29 [文献标识码] A [文章编号] 1672-4062(2017)08(a)-0009-02

    Observation on Clinical Curative Effect of Mentyao Jiangtangyihao Capsule in Treatment of Diabetes

    LIANG Si-qin

    Department of Pharmacy, Affiliated Hospital of Inner Mongolia University for the Nationalities, Tongliao, Inner Mongolia, 028000 China

    [Abstract] Objective To study the clinical curative effect of mentyao Jiangtangyihao capsule in treatment of diabetes. Methods 160 cases of diabetes patients admitted and treated in our hospital from April 2016 to April 2017 were selected as the observation objects and randomly divided into two groups with 80 cases in each, the control group were treated with glyburide, while the research group were treated with mentyao Jiangtangyihao capsule, for 4 weeks in a row, and the treatment effect was observed. Results The total effective rate in the research group was obviously better than that in the control group(P<0.05), and the adverse reactions in the research group was obviously lower than that in the control group(P<0.05), and the various hemorheology indicators after treatment in the research group were improved(P<0.05). Conclusion The mentyao Jiangtangyihao capsule can effectively relieve the clinical symptoms, reduce the blood glucose, improve the hemorheology indicators, reduce the pains of patients, improve the quality of life, optimize the treatment effect, and reduce the adverse reactions, and the curative effect is safe and reliable, and it is worth application.

    [Key words] Diabetes; Mentyao jiangtangyihao capsule; Clinical effect

    糖尿病是指因遺传、免疫功能紊乱、环境等因素导致机体胰岛功能衰竭,胰岛素分泌不足,胰岛素作用缺陷引起蛋白质、脂肪、水、糖、电解质等一系列代谢紊乱,引起以高血糖为特征的代谢障碍或代谢旺盛[1]。长期内分泌代谢紊乱和持续高血糖会导致全身各个系统病变,尤其是眼、心脑血管、肾、下肢等部位,易对神经系统损伤,导致功能障碍和衰竭,严重者可导致水、电解质紊乱、酸碱平衡失调,引起中毒和昏迷,严重影响患者正常生活、工作,威胁患者的生命安全[2]。持续高血糖是糖尿病患者的基本特征,正常人在清晨空腹血糖浓度为80~120 mg/dL,糖尿病患者清晨空腹血糖超过130 mg/dL,血糖升高,尿糖增多,大量水分流失,增加血渗透压,从而引起患者口渴、多饮、多尿的症状。由于患者机体胰岛素相对或绝对缺乏,导致体内葡萄糖不能被利用,蛋白质、脂肪消耗增多,引起患者出现乏力、消瘦等症状。由于尿糖丢失、高血糖刺激胰岛素分泌,患者易产生饥饿感,引起患者出现多食的症状。健康教育、药物治疗、运动治疗、饮食治疗、胰岛素治疗等方法是治疗糖尿病的主要方法。该文对2016年4月—2017年4月收治的80例糖尿病患者给予蒙药希合日希精阿日乐嘎其(降糖1号)治疗的临床疗效进行分析,现报道如下。, http://www.100md.com(梁斯琴)
1 2下一页